You do seem to like a good argument @djbenton75 , I'll give...

You do seem to like a good argument @djbenton75 , I'll give you that.

But atleast try to include the full picture....

The stock to which you refer, which I won't name, so as not to offend your cross promotion sensitivities, traded at $6.38 yesterday prior to the announcement they had received the FTD. Today it closed at $6.72, and increase of 5.3%

But anyway, facts aside, my point (opinion) also was that some of the profits made by investors in that stock over the medium term, may well be recycled into RAC at some point, especially given the apparent cross-over of shareholders and where each company is in its clinical development. But hey, I could be wrong, it's just my opinion !

Anyway, enjoy your evening & have an extra shot of courage for me